Abstract
A systematic review and meta-analysis were performed to identify if there is a subset of patients with POI who are more likely to show follicular growth after ovarian fragmentation for follicular activation (OFFA) or in vitro activation (IVA). Five studies met inclusion criteria for meta-analysis with a total of 164 patients. Forty-three patients showed follicle development (26.21%). Of those, the pregnancy rate was 35.58% (11/43) and the live birth rate was 20.93% (9/43). Our meta-analysis showed that age was not associated with follicle growth. However, lower baseline FSH, lower duration of amenorrhea/diagnosis, and presence of follicles remaining in biopsy were statistically significant for follicle development. Patients with basal characteristics mentioned before may have more chances to show follicle growth after OFFA or IVA. Taking into account that approximately 20% of patients with follicle growth had live birth, these results are very promising. Given the overall certainty of evidence, future studies are needed to confirm said results.
Similar content being viewed by others
Data Availability
The data underlying this article will be shared on reasonable request to the corresponding author.
References
Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67:604–6.
European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI, Webber L, Davies M, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926–37. https://doi.org/10.1093/humrep/dew027.
Devenutto L, Quintana R, Quintana T. In vitro activation of ovarian cortex and autologous transplantation: a novel approach to primary ovarian insufficiency and diminished ovarian reserve. Hum Reprod Open. 2020;2020:hoaa046.
Pellicer N, Cozzolino M, Diaz-García C, Galliano D, Cobo A, Pellicer A, et al. Ovarian rescue in women with premature ovarian insufficiency: facts and fiction. Reprod Biomed Online. 2023;46:543–65.
Hsueh AJW, Kawamura K. Hippo signaling disruption and ovarian follicle activation in infertile patients. Fertil Steril. 2020;114:458–64.
Kawamura K, Cheng Y, Suzuki N, Deguchi M, Sato Y, Takae S, et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci. 2013;110:17474–9.
Suzuki N, Yoshioka N, Takae S, Sugishita Y, Tamura M, Hashimoto S, et al. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Hum Reprod. 2015;30:608–15.
Zhai J, Yao G, Dong F, Bu Z, Cheng Y, Sato Y, et al. In vitro activation of follicles and fresh tissue auto-transplantation in primary ovarian insufficiency patients. J Clin Endocrinol Metab. 2016;101:4405–12.
Ferreri J, Fàbregues F, Calafell JM, Solernou R, Borrás A, Saco A, et al. Drug-free in-vitro activation of follicles and fresh tissue autotransplantation as a therapeutic option in patients with primary ovarian insufficiency. Reprod Biomed Online. 2020;40:254–60.
Méndez M, Fabregues F, Ferreri J, Calafell JM, Villarino A, Otero J, et al. Biomechanical characteristics of the ovarian cortex in POI patients and functional outcomes after drug-free IVA. J Assist Reprod Genet. 2022;39:1759–67.
Steiner AZ. Evidence that biopsying, fragmentation and auto-transplantation of ovarian tissue should be abandoned as a treatment of diminished ovarian reserve. Hum Reprod. 2019;34:1853–4.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535–b2535.
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210.
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions. 2nd ed. Chichester (UK): John Wiley & Sons; 2019.
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355: i4919.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.
Fabregues F, Ferreri J, Calafell JM, Moreno V, Borrás A, Manau D, et al. Pregnancy after drug-free in vitro activation of follicles and fresh tissue autotransplantation in primary ovarian insufficiency patient: a case report and literature review. J Ovarian Res. 2018;11:76.
Ferreri J, Méndez M, Calafell JM, Fábregues F. Long-term outcome of ovarian function after drug-free in vitro activation (IVA) in primary ovarian insufficiency patient. JBRA Assist Reprod [Internet]. 2021 [cited 2023 May 13];25. Available from: https://www.jbra.com.br/trab/pub/download_trabalho.php?fileSource=/var/www/vhosts/jbra.com.br/media/trab/arq_2665&fileName=24%20-%201644-Long-term.pdf&id_trabalho=926.
Kawamura K, Kawamura N, Hsueh AJW. Activation of dormant follicles: a new treatment for premature ovarian failure? Curr Opin Obstet Gynecol. 2016;28:217–22.
Patel N, Bhadarka H, Patel N, Patel M. Drug-free in vitro activation for primary ovarian insufficiency. J Hum Reprod Sci. 2021;14:443.
Jprn-Umin000029807. Cryopreservation and autografting of ovarian tissues for infertility treatment in patients with primary ovarian in sufficiency (POI). Httpwwwwhointtrialsearchtrial2aspx Trialidjprn-Umin000029807. 2017.
Melado L. Is there a role for mechanical stimulation in ovarian follicular activation? A randomized control trial. [Internet]. clinicaltrials.gov; 2022 Jul. Report No.: NCT04390308. Available from: https://clinicaltrials.gov/ct2/show/NCT04390308.
Mahmoud K, Elloumi H, Khrouf M, Habib Ben Aribia M, Terras K, Mnallah S, et al. Interest of the use auto-transplantation of the ovarian cortex after dormant follicles in vitro activation in patients with premature ovarian insufficiency. Fertil Steril. 2019;112:e386.
Tanaka Y, Hsueh AJ, Kawamura K. Surgical approaches of drug-free in vitro activation and laparoscopic ovarian incision to treat patients with ovarian infertility. Fertil Steril. 2020;114:1355–7.
Zhang L, Zhang J, Zhai J, Liu X, Deng W, Wang H, et al. Autotransplantation of the ovarian cortex after in-vitro activation for infertility treatment: a shortened procedure. Hum Reprod. 2021;36:2134–47.
Zhang X, Han T, Yan L, Jiao X, Qin Y, Chen Z-J. Resumption of ovarian function after ovarian biopsy/scratch in patients with premature ovarian insufficiency. Reprod Sci. 2019;26:207–13.
Bachelot A, Nicolas C, Bidet M, Dulon J, Leban M, Golmard JL, et al. Long-term outcome of ovarian function in women with intermittent premature ovarian insufficiency. Clin Endocrinol (Oxf). 2017;86:223–8.
Ishizuka B, Furuya M, Kimura M, Kamioka E, Kawamura K. Live birth rate in patients with premature ovarian insufficiency during long-term follow-up under hormone replacement with or without ovarian stimulation. Front Endocrinol. 2021;12: 795724.
Harkki-Sirén P, Kurki T. A nationwide analysis of laparoscopic complications. Obstet Gynecol. 1997;89:108–12.
Jansen FW, Kapiteyn K, Trimbos-Kemper T, Hermans J, Trimbos JB. Complications of laparoscopy: a prospective multicentre observational study. BJOG Int J Obstet Gynaecol. 1997;104:595–600.
Magrina JF. Complications of laparoscopic surgery. Clin Obstet Gynecol. 2002;45:469.
Wang W, Todorov P, Isachenko E, Rahimi G, Mallmann P, Wang M, et al. In vitro activation of cryopreserved ovarian tissue: a single-arm meta-analysis and systematic review. Eur J Obstet Gynecol Reprod Biol. 2021;258:258–64.
Author information
Authors and Affiliations
Contributions
J.A.E.B. conceived the idea of the study. All authors contributed to the study design and protocol development. J.A.E.B. and M.R.D. performed the search. J.A.E.B. and M.R.D. extracted the data. M.T.M and D.E.H.G performed the analysis. J.A.E.B., M.T.M., F.C., and F.F. drafted the manuscript. All authors interpreted the data, critically revised the article, and approved the final version.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Escarcega-Bordagaray, J.A., Torres-Martinez, M., Hinojosa-Gonzalez, D.E. et al. Basal characteristics of patients who responded to Ovarian Fragmentation for Follicular Activation (OFFA) or In Vitro Activation (IVA): a systematic review and meta-analysis. J Assist Reprod Genet 41, 989–998 (2024). https://doi.org/10.1007/s10815-024-03046-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-024-03046-4